Refine
Has Fulltext
- yes (88)
Is part of the Bibliography
- yes (88)
Year of publication
- 2016 (88) (remove)
Document Type
- Journal article (88) (remove)
Keywords
- DNA methylation (3)
- Drosophila (3)
- Drosophila melanogaster (3)
- biodiversity (3)
- circadian rhythms (3)
- vision (3)
- DNA damage (2)
- Spermatogenesis (2)
- biological locomotion (2)
- breast cancer (2)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (88) (remove)
Sonstige beteiligte Institutionen
Human papilloma virus (HPV) is the primary etiological agent responsible for cervical cancer in women. Although in total 16 high-risk HPV strains have been identified so far. Currently available commercial vaccines are designed by targeting mainly HPV16 and HPV18 viral strains as these are the most common strains associated with cervical cancer. Because of the high level of antigenic specificity of HPV capsid antigens, the currently available vaccines are not suitable to provide cross-protection from all other high-risk HPV strains. Due to increasing reports of cervical cancer cases from other HPV high-risk strains other than HPV16 and 18, it is crucial to design vaccine that generate reasonable CD8+ T-cell responses for possibly all the high-risk strains. With this aim, we have developed a computational workflow to identify conserved cross-clade CD8+ T-cell HPV vaccine candidates by considering E1, E2, E6 and E7 proteins from all the high-risk HPV strains. We have identified a set of 14 immunogenic conserved peptide fragments that are supposed to provide protection against infection from any of the high-risk HPV strains across globe.